US Metabolic Surgery Market Industry Trends and Forecast to 2034: Segmented by (Procedure, Approach, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$4.35 BnPlaceholder estimate
Estimate 2025$4.53 Bn44.4% of the global market
Projected 2034$6.50 Bn 43.6%Adds $1.97 Bn over 9 forecast years
CAGR 2025–20344.1%Faster than 12% of 107 Healthcare Services markets here
Key players5
US is 44.35% of the global market.
In North America, the largest is US (this report) at $4.53 Bn.
Medtronic, Johnson & Johnson, Intuitive Surgical, Olympus Corporation, Teleflex Inc (see all)
Active clinical trials
114 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The US Metabolic Surgery Market Analysis Executive Summary
Metabolic surgery uses weight-loss operations to treat type 2 diabetes and other metabolic diseases, not only to reduce weight.
Key segments of the metabolic Surgery market include procedure (Sleeve Gastrectomy, Roux-en-Y Gastric Bypass and Duodenal Switch) and approach (Laparoscopic, Robotic-Assisted and Endoscopic).
US Metabolic Surgery market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
US Metabolic Surgery Market Dynamics
Market Growth Drivers
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the metabolic Surgery market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Opportunity
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the metabolic Surgery market, especially in fast-growing emerging economies.
Market Restraints
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the metabolic Surgery market. Long-term safety data and lifestyle support are still needed for many patients.
Competitive Landscape for Metabolic Surgery Market in US
The metabolic Surgery market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Metabolic Surgery Market in US
Metabolic Surgery in the US: payment and research
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[1] ClinicalTrials.gov lists 114 studies on Metabolic Surgery that are recruiting, active or about to start in the US.[2] Obesity (adults): 41.0% of adults in 2024, the latest WHO figure for the US.[3]
Licensing, quality standards and payment models from public and private payers shape how metabolic Surgery services are delivered and paid for in US. Government health programs and insurance coverage are key to access.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Procedure
4.2 By Approach
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Medtronic
7.2 Johnson & Johnson MedTech
7.3 Intuitive Surgical
7.4 Olympus Corporation
7.5 Teleflex
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The metabolic Surgery market can be segmented based on various criteria, including procedure, approach and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Metabolic Surgery right now, from free public sources.
How big is the Metabolic Surgery market in the US?
Placeholder estimate: about $4.53 Bn in 2025, rising to about $6.50 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Metabolic Surgery market in the US growing?
Placeholder estimate: about 4.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Metabolic Surgery market report cover?
The report splits the market by procedure (Sleeve Gastrectomy, Roux-en-Y Gastric Bypass, Duodenal Switch, Revisional Surgery), approach (Laparoscopic, Robotic-Assisted, Endoscopic) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Metabolic Surgery market?
Key players include Medtronic, Johnson & Johnson, Intuitive Surgical, Olympus Corporation and Teleflex Inc.
What is driving the Metabolic Surgery market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the metabolic Surgery market.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Metabolic Surgery are running in the US?
114 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
What does WHO report for the US?
Obesity (adults): 41.0% of adults in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.
How many people in the US are 65 or older?
18.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 17 Nov 2026.
How much research is published on Metabolic Surgery?
PubMed lists 1,452 papers on Metabolic Surgery added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.